Building Heart Valves From Extracellular MatrixBuilding Heart Valves From Extracellular Matrix https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Abbie Roth Abbie Roth https://pediatricsnationwide.org/wp-content/uploads/2021/02/062019ds5821_abbie-profile-new.jpg
- November 21, 2017
- Abbie Roth
Physicians at Nationwide Children’s Hospital describe the use of an extracellular matrix cylindar valve in the mitral position.
At The Heart Center at Nationwide Children’s, Patrick McConnell, MD, a pediatric cardiothoracic surgeon, is using an alternative to the traditional cadaveric, mechanical or biological replacement valve. In a recent case report published in Echocardiography, Dr. McConnell and his colleagues describe the use of an extracellular matrix (ECM) cylinder valve (CV) in the mitral valve position of a 15-month-old child.
For the mitral valve in patients of this age, the traditional choices would be a cadaveric valve or a mechanical valve. Both have significant drawbacks. While Dr. McConnell asserts that the ECM-CV isn’t “magic,” it does offer some significant benefits to young patients.
For example, the size can be customized for each heart. Patients don’t need anticoagulant therapy. Unlike other replacement valves, the ECM valves can been stretched during a catheterization procedure to improve flow as the child grows.
“Our experience with ECM valves tells us that these valves can reduce the number of interventions, and reduce the invasiveness of the required intervention, compared to traditional approaches to mitral valve replacement in children,” says Dr. McConnell, who is also an assistant professor of Surgery at The Ohio State University College of Medicine.
In the case report, the child, as discharged on postoperative day six. According to Dr. McConnell, for children who receive mechanical valves, a hospital stay of 45 days postop is not uncommon to get the anticoagulation right.
Three months after Dr. McConnell placed the valve, the patient showed no significant mitral stenosis and not significant regurgitation. The parents reported that the child was back to baseline activity as well.
“While long- and mid-term outcomes for these valves in the pediatric population are unknown, we’ve shown that excellent short-term outcomes are achievable,” says Dr. McConnell.
Dr. McConnell and his colleagues continue to follow patients, like the one in this case report, who have received ECM mitral valves as well as patients who receive ECM pulmonary valves with conduits. They plan to publish results from these patients in the future.
Cua CL, Johnston P, Harmon J, Shelton K, McConnell, PI. Custom extracellular matrix cylinder mitral valve in a pediatric patient. Echocardiography. 2017: DOI; 10.1111/echo.13702.
About the author
- Posted In:
- In Brief
You might also like
Standardizing Training in Pediatric Cardiac Critical CareStandardizing Training in Pediatric Cardiac Critical Care https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Mary Bates, PhD Mary Bates, PhD https://secure.gravatar.com/avatar/c6233ca2b7754ab7c4c820e14eb518c8?s=96&d=mm&r=g
How Patient-Derived Stem Cells are Changing the Trajectory of Congenital Heart Disease ResearchHow Patient-Derived Stem Cells are Changing the Trajectory of Congenital Heart Disease Research https://pediatricsnationwide.org/wp-content/uploads/2021/10/iStock_000014186415XLarge-1024x683.jpg 1024 683 Katie Brind'Amour, PhD, MS, CHES Katie Brind'Amour, PhD, MS, CHES https://pediatricsnationwide.org/wp-content/uploads/2021/03/Katie-B-portrait.gif
Stent Implantations Are an Option for Small PatientsStent Implantations Are an Option for Small Patients https://pediatricsnationwide.org/wp-content/uploads/2020/09/AdobeStock_93001580-1024x670.jpg 1024 670 Mary Bates, PhD Mary Bates, PhD https://secure.gravatar.com/avatar/c6233ca2b7754ab7c4c820e14eb518c8?s=96&d=mm&r=g